Nuvectis Pharma
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $-4,101 |
Gross Profit | -4,643 | -4,396 | -15,068 |
EBITDA | -4,643 | -4,396 | -6,866 |
EBIT | -4,439 | -5,866 | |
Net Income | -4,428 | -4,171 | -6,622 |
Net Change In Cash | 0 | 0 | -4,101 |
Free Cash Flow | -3,020 | -4,358 | -3,850 |
Cash | 18,116 | 19,464 | 19,126 |
Basic Shares | 16,900 | 16,559 | 17,418 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $149 | $0 |
Gross Profit | -22,897 | -19,085 | -12,894 |
EBITDA | -22,897 | -18,936 | -12,890 |
EBIT | -21,897 | -19,234 | -12,894 |
Net Income | -22,260 | -18,787 | -12,886 |
Net Change In Cash | 0 | 149 | 0 |
Cost of Revenue | 14,251 | ||
Free Cash Flow | -15,954 | -13,559 | -9,504 |
Cash | 19,126 | 19,993 | 5,742 |
Basic Shares | 15,556 | 12,657 | 12,717 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.24 |
2024-06-30 | -$0.26 |
2024-03-31 | -$0.25 |
2023-12-31 | -$0.41 |
